Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning

Published:2018-09-18 Issue:4 Volume:101 Page:466-474
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Robin Marie¹²^ORCID,Raj Kavita³,Chevret Sylvie⁴^ORCID,Gauthier Jordan⁵,de Lavallade Hugues³,Michonneau David¹⁶,McLornan Donal³,Peffault de Latour Régis¹,Potter Victoria³,Kulasekararaj Austin³,Sicre de Fontbrune Flore¹,Pagliuca Antonio³,Yakoub-Agha Ibrahim⁴,Socié Gérard¹⁶,Mufti Ghulam J.³

Affiliation:

1. Service d'hématologie greffe; Hôpital Saint-Louis; APHP; Paris France

2. INSERM 1131 Université Paris 7; Paris France

3. Department of Haematological Medicine; Kings College Hospital and Kings College London; London UK

4. Service de biostatistique; Hôpital Saint-Louis; APHP; Université Paris 7; Paris France

5. CHU de Lille; LIRIC INSERM U955; Université Lille2; Paris France

6. INSERM 1160 Université Paris 7; Paris France

Funder

EHA short term collaboration

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13085/fullpdf

Reference33 articles.

1. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001

2. Antilymphocyte globulin for prevention of chronic graft-versus-host disease;Kröger;N Engl J Med,2016

3. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial;Walker;Lancet Oncol,2016

4. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial;Finke;Lancet Oncol,2009

5. Prospective, randomized, double-blind, phase III clinical trial of anti-T-lymphocyte globulin to assess impact on chronic graft-versus-host disease-free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation;Soiffer;J Clin Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of interleukin-2 in graft-versus-host disease pathogenesis, prevention and therapy;Cytokine;2024-11

2. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Cochrane Database of Systematic Reviews;2023-06-21

3. Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2022-02-26

4. Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models;PLOS ONE;2021-01-11

5. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation;Journal of Clinical Immunology;2020-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3